According to a previous report, TYRO3 and AXL were not expressed in normal thyroid cells, but showed remarkably increased expression in thyroid cancer cells, thereby contributing to the resistance of thyroid cancer to existing targeted treatments (Avilla et al., 2011). Here, AXL is linked to thyroid gland carcinoma.